U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198607) titled 'Pistacia Lentiscus Oil Nasal Drops for Preventing Recurrence of Chronic Rhinosinusitis' on S... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199673) titled 'Comparison of Outcome of Injection Sclerotherapy Versus Rubber Band Ligation for Second Degr... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199777) titled 'A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patient... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198763) titled 'Comparison Between Conventional Rehabilitation and Conventional Rehabilitation Through Dance... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199543) titled 'Palatability Study of Five Formulations of Benzydamine HCl Lozenges' on Sept. 09. Brief Sum... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198581) titled 'AI-Assisted Chemotherapy Side Effect Management' on Sept. 03. Brief Summary: This two-stage... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198932) titled 'Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes' on Sept. 19. ... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199088) titled 'Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199010) titled 'Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression'... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199855) titled 'Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph... Read More